Thrombophilia, also called hypercoagulability or prothrombotic condition, usually reflects a
certain imbalance that occurs either in the coagulation cascade or in the anticoagulation …

The assessment of hemostasis is necessary to make suitable decisions on the management
of patients with thrombotic disorders. In some clinical situations, for example, during …

Hereditary antithrombin deficiency is caused by SERPINC1 gene mutations and
predisposes to recurrent venous thromboembolism that can be life-threatening. Therefore …

Background: Direct oral anticoagulants (DOACs) cause unwanted interference in various
hemostasis assays, including lupus anticoagulant (LA) testing, where false positive and …

A major advancement in the field of medicine has been the introduction and usage of direct
oral anticoagulants (DOACs) such as dabigatran (Pradaxa), apixaban (Eliquis), and …

Objectives to evaluate direct oral anticoagulants (DOACs) in patients with hereditary
thrombophilia and deep venous thrombosis (DVT). Methods This is a retrospective …

Background Post-thrombotic syndrome (PTS) is the main long-term complication of deep
vein thrombosis (DVT). Several therapies are being evaluated to prevent or to treat PTS …

Cardiovascular diseases, among which includes coronary artery disease, represent one of
the most important causes of mortality and morbidity worldwide. Research aimed at …

Abstract Combined thrombophilia represents 7.8–8.3% of the patients with thrombophilia
and confers a higher risk for thrombosis development and recurrence. Here, we present a 17 …

Background: Despite pregnancy's hypercoagulable state, the correlation between inherited
thrombophilia and thrombotic adverse pregnancy outcomes remains uncertain. The …